US-Nanotechnology Characterization Lab Scott McNeil, PhD Director Workshop Session 7: EU-US and International cooperation NMBP 14-2017: Regulatory Science.
Chapter 2: Ethical Considerations in Mental Health Treatment and Interventions with School-Age Children and Adolescents Adam L. Fried Celia B. Fisher.
Midterm Review
Theory of Human Caring
QST for phase 2 trials Long-term neuropathic and non-neuropathic conditions Per Hansson, MD, DMSci, DDS Karolinska Instituet, Karolinska University Hospital.
Treatment of Aspergillosis John R. Perfect Duke University Medical Center.
PK/PD - ICC - Manila, June 5th, 20051 The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul.
Partial proceeds from this training goes to the Hidden Angel Foundation
Professional Patient Advocate
QST for phase 2 trials Long-term neuropathic and non-neuropathic conditions
